Mobileye Global Inc MBLY stock surged after BofA Securities analyst John P. Babcock upgraded it from Underperform to Neutral and raised its price target from $12 to $19.

Investors drawn to WBA and CVS must feel disappointed. WBA's recent dividend suspension and CVS's dividend freeze reflect financial headwinds and operational challenges. I won't consider either as a buy candidate.

The Trade Desk's fourth-quarter 2024 performance is likely to have benefited from the growing CTV momentum and expanding partner base amid stiff competition.

Alerus (ALRS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

CleanSpark (CLSK) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Tyson (TSN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Zions (ZION) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Grocery Outlet Holding Corp. ("Grocery Outlet" or the "Company") (NASDAQ: GO) of a class action securities lawsuit.

Other automakers skipped Super Bowl advertising this year, but CMO Olivier Francois said it was critical for Jeep and Ram parent company Stellantis to air ads during the game. Stellantis, formerly Fiat Chrysler, has become well-known under Francois for symbolic, nontraditional ads that feature iconic celebrities or tell a story beyond just attempting to sell new cars and trucks.

NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Sun Communities, Inc. ("Sun Communities, Inc." or the "Company") (NYSE: SUI) of a class action securities lawsuit.

Tesla, Inc.'s stock has experienced significant volatility, with the +82.7% rally (after our last article) and subsequent -24.6% correction highlighting the risks of the momentum trading strategy. For now, the company's well diversified capability across energy/ storage/ services are showing robust monetization opportunities, with bright long-term prospects. Its EV production and delivery numbers are likely to improve in FY2025 as well, with the trough FY2024 performance merely attributed to the battery supply constraints.

Transaction in Own Shares 10 February, 2025 • • • • • • • • • • • • • • • • Shell plc (the ‘Company') announces that on 10 February 2025 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading venue: Date of purchase Number of Shares purchased Highest price paid Lowest price paid Volume weighted average price paid per share Venue Currency 10/02/2025 894,839 £ 26.5300 £ 26.1950 £ 26.4253 LSE GBP 10/02/2025 105,161 £ 26.5050 £ 26.2000 £ 26.4083 Chi-X (CXE) GBP 10/02/2025 100,000 £ 26.5050 £ 26.2100 …

NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Caribou Biosciences, Inc. ("Caribou Biosciences, Inc." or the "Company") (NASDAQ: CRBU) of a class action securities lawsuit.

NEW YORK , Feb. 10, 2025 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm by ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Playa Hotels & Resorts N.V.

American Express Company (NYSE:AXP ) UBS Financial Services Conference February 10, 2025 10:30 AM ET Company Participants Christophe Le Caillec - Chief Financial Officer Conference Call Participants Erika Najarian - UBS Erika Najarian Hey, everybody. Thanks again for joining us.

UBS should have more clarity on the amount of capital it will need to hold under new Swiss banking regulations currently being drawn up, CEO Sergio Ermotti said on Monday.

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Joint Stock Company Kaspi.kz (NASDAQ:KSPI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/joint-stock-company-kaspi-kz-lawsuit-submission-form?prid=128461&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your ModivCare Inc. (NASDAQ:MODV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/modivcare-inc-lawsuit-submission-form?prid=128463&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Joint Stock Company Kaspi.kz (NASDAQ:KSPI) between January 19, 2024 and September 19, 2024, both dates inclusive (the "Class Period"), of the important February 18, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Kaspi.kz securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

NEW YORK, NY / ACCESS Newswire / February 10, 2025 / If you suffered a loss on your Caribou Biosciences, Inc. (NASDAQ:CRBU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/caribou-biosciences-inc-lawsuit-submission-form?prid=128464&wire=1 or contact Joseph E. Levi, Esq.